الفهرس | Only 14 pages are availabe for public view |
Abstract Atherosclerosis is a multifactorial disease of the large arteries which requires a lipid component (hypercholesterolemia) and an inflammatory component for its development and progression. Many studies have shown that atherosclerosis is an inflammatory disease of the injured vascular walls and does not result simply from the accumulation of lipids. Thus, acute phase reactants such as fibrinogen, Creactive protein (CRP) and platelets are recognized as new risk factors for atherosclerosis. The healthy liver plays an essential role in production of many coagulation factors including fibrinogen, lipoprotein particles as well as some inflammatory cytokines including CRP, which are risk factors for atherosclerosis. Hepatitis C virus is a major public health problem in Egypt specially genotype 4. Egypt has the highest world wide prevalence, with 9% country wide and up to 50% in certain rural areas. Some studies have reported a higher prevalence of cardiovascular risk factors, carotid atherosclerosis and coronary heart disease among individuals with hepatitis C infection. In contrast, other studies have reported no association between hepatitis C infection and cardiovascular risk factors, carotid atherosclerosis and coronary heart diseas. ٨٠ SUMMARY AND CONCLUSION The association between hepatitis C virus infection and CAD is less clear. A small number of reported studies have shown conflicting results; some have reported no association between HCV infection and CAD, where as others have reported an increased risk or an increase in measures of subclinical atherosclerosis. The increased risk of CAD in HCV infected persons may be related to a differential level of cytokines, which are markers of inflammation, thrombosis, and endothelial dysfunction. Chronic HCV infection could be considered a chronic inflammatory process that might play a role in the pathogenesis of carotid arterial remodeling. Aim of study: This study hade been designed to evaluate the relation ship between chronic HCV infection and atherosclerotic changes in Egyptian patients. Patients and methods The present study was conducted on 40 chronic HCV patients as cases and 10 healthy persons as controls. In this study we excluded any patients with diabetes mellitus, obesity (BMI 30), HBsAg + Ve and hepatocellular carcinoma as other factors can affect atherosclerosis development other than HCV infection. |